Systemic side effects associated with the ophthalmic administration of timolol. 1985

W P Munroe, and J P Rindone, and R M Kershner

Since the introduction of ophthalmic timolol solution in 1978 there have been numerous reports of systemic toxicity associated with its use. The majority of the systemic side effects reported are the same as those associated with oral timolol. Several cases of respiratory distress have been described generally in patients with underlying restrictive airway disease. Cardiovascular effects range from effects on resting pulse rate to the development of overt bradycardia and heart failure. Central nervous system effects reported include fatigue, confusion, depression, and hallucinations. A variety of other systemic effects have also been described. Caution should be used when ophthalmic timolol is administered to elderly patients or those patients with contraindications to systemic beta-blockers.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease

Related Publications

W P Munroe, and J P Rindone, and R M Kershner
January 1987, Journal of ocular pharmacology,
W P Munroe, and J P Rindone, and R M Kershner
February 1985, Journal of the American Optometric Association,
W P Munroe, and J P Rindone, and R M Kershner
December 1980, Harefuah,
W P Munroe, and J P Rindone, and R M Kershner
January 2007, Scandinavian journal of clinical and laboratory investigation,
W P Munroe, and J P Rindone, and R M Kershner
January 2004, Clinical pediatrics,
W P Munroe, and J P Rindone, and R M Kershner
April 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W P Munroe, and J P Rindone, and R M Kershner
December 1992, Harefuah,
W P Munroe, and J P Rindone, and R M Kershner
April 1990, DICP : the annals of pharmacotherapy,
W P Munroe, and J P Rindone, and R M Kershner
February 1986, Annals of internal medicine,
W P Munroe, and J P Rindone, and R M Kershner
March 1980, The Journal of the Maine Medical Association,
Copied contents to your clipboard!